Voters weigh Proposition 38’s $8.4 billion general obligation bond against its projected $500–600 million annual General Fund repayment cost over roughly 20 years. The measure’s allocation of half the proceeds to one University of California-affiliated institute, selected by the Department of Public Health, has drawn scrutiny over earmarking and limited competitive peer review for that portion. Supporters highlight requirements for independent audits, a 20 percent price discount on resulting therapies for California patients, and potential future royalty offsets, yet the immediate debt service and budget impact appear to shape trader consensus favoring rejection ahead of the November 3, 2026 ballot.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
21% 確率
新規
新規
2026/11/03
はい
21% 確率
新規
新規
2026/11/03
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s.
This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”
If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.
This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).Voters weigh Proposition 38’s $8.4 billion general obligation bond against its projected $500–600 million annual General Fund repayment cost over roughly 20 years. The measure’s allocation of half the proceeds to one University of California-affiliated institute, selected by the Department of Public Health, has drawn scrutiny over earmarking and limited competitive peer review for that portion. Supporters highlight requirements for independent audits, a 20 percent price discount on resulting therapies for California patients, and potential future royalty offsets, yet the immediate debt service and budget impact appear to shape trader consensus favoring rejection ahead of the November 3, 2026 ballot.
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s.
This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”
If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.
This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”
If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.
This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
マーケット開始日： Jul 1, 2026, 6:33 PM ET
音量
$2,892終了日
2026/11/03マーケット開始日
Jul 1, 2026, 6:33 PM ETリゾルバー
0x65070BE91...Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s.
This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”
If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.
This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).Voters weigh Proposition 38’s $8.4 billion general obligation bond against its projected $500–600 million annual General Fund repayment cost over roughly 20 years. The measure’s allocation of half the proceeds to one University of California-affiliated institute, selected by the Department of Public Health, has drawn scrutiny over earmarking and limited competitive peer review for that portion. Supporters highlight requirements for independent audits, a 20 percent price discount on resulting therapies for California patients, and potential future royalty offsets, yet the immediate debt service and budget impact appear to shape trader consensus favoring rejection ahead of the November 3, 2026 ballot.
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s.
This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”
If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.
This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”
If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.
This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
音量
$2,892終了日
2026/11/03マーケット開始日
Jul 1, 2026, 6:33 PM ETリゾルバー
0x65070BE91...Voters weigh Proposition 38’s $8.4 billion general obligation bond against its projected $500–600 million annual General Fund repayment cost over roughly 20 years. The measure’s allocation of half the proceeds to one University of California-affiliated institute, selected by the Department of Public Health, has drawn scrutiny over earmarking and limited competitive peer review for that portion. Supporters highlight requirements for independent audits, a 20 percent price discount on resulting therapies for California patients, and potential future royalty offsets, yet the immediate debt service and budget impact appear to shape trader consensus favoring rejection ahead of the November 3, 2026 ballot.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問